Donald Schon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Donald Schon has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Rick Mishler
Arizona Kidney Disease and Hypertension Surgery Center, Phoenix, Arizona
2 shared publicationsChristina Wyatt
Division of Nephrology, Mount Sinai Medical Center, New York, New York
1 shared publicationDavid Whittman
Renal Section, University of Arizona Health Sciences Center, Phoenix, Arizona
1 shared publicationJoseph Assalotti
Division of Nephrology, Mount Sinai Medical Center, New York, New York
1 shared publicationKamla Takesian
Arizona Kidney Disease and Hypertension Surgery Center, Phoenix, Arizona
1 shared publicationKaveh Kian
Division of Nephrology, Mount Sinai Medical Center, New York, New York, USA
1 shared publication
Latest Publications
- 24 October 2012
- Published by Wiley in Seminars in Dialysis
- Vol. 26 (3) , 344-348
Comparison of Procedure Cost for Thrombectomy of Arteriovenous Fistulas and Grafts
Expenditures on dialysis vascular access now exceed $2.5 Billion annually in the US. Studies suggest that significant savings could be achieved by increasing arteriovenous fistula (AVF) prevalence to >65%. It is common but unsubstantiated opinion that AVF have lower maintenance costs than arteriovenous grafts (AVG). This manuscript tests this hypothesis by direct comparison. Equipment utilization time and supply utilization on 110 thrombectomy procedures on AVF and 258 on AVG were compared. Procedures techniques were standardized within one facility and procedures performed by a multiple but limited number of operators. There were no significant differences in demographic variables and comorbid factors between groups. Time to complete AVF thrombectomy was 1.7 times that for AVG. In addition, major supplies used such as wires and balloons were also significantly greater. Interventionists who took longer than average to thrombectomize AVF took longer than average to thrombectomize AVG. The prevalence of arterial inflow lesions was 1.5 greater in thrombosed AVF versus Thrombosed AVG. Procedure costs when analyzed in terms of procedure time, room utilization, staff, and equipment are significantly greater for thrombosed AVF than thrombosed AVG.
- 24 October 2012
- Published by Wiley in Seminars in Dialysis
- Vol. 26 (3) , 344-348
Comparison of Procedure Cost for Thrombectomy of Arteriovenous Fistulas and Grafts
Expenditures on dialysis vascular access now exceed $2.5 Billion annually in the US. Studies suggest that significant savings could be achieved by increasing arteriovenous fistula (AVF) prevalence to >65%. It is common but unsubstantiated opinion that AVF have lower maintenance costs than arteriovenous grafts (AVG). This manuscript tests this hypothesis by direct comparison. Equipment utilization time and supply utilization on 110 thrombectomy procedures on AVF and 258 on AVG were compared. Procedures techniques were standardized within one facility and procedures performed by a multiple but limited number of operators. There were no significant differences in demographic variables and comorbid factors between groups. Time to complete AVF thrombectomy was 1.7 times that for AVG. In addition, major supplies used such as wires and balloons were also significantly greater. Interventionists who took longer than average to thrombectomize AVF took longer than average to thrombectomize AVG. The prevalence of arterial inflow lesions was 1.5 greater in thrombosed AVF versus Thrombosed AVG. Procedure costs when analyzed in terms of procedure time, room utilization, staff, and equipment are significantly greater for thrombosed AVF than thrombosed AVG.
- 17 July 2007
- Published by Wiley in Seminars in Dialysis
- Vol. 20 (4) , 346-350
Efficiency and Outcomes of Emergent Vascular Access Procedures Performed at a Dedicated Outpatient Vascular Access Center
The outpatient vascular access center (VAC) may have an important impact in improving the outcomes of emergent procedures on nonfunctioning hemodialysis access. An emergent procedure is defined as the absence of a functioning access for hemodialysis, including thrombosed graft or fistula, nonfunctioning dialysis catheters, and the need for access to initiate emergent hemodialysis. The aim of this study was to prospectively evaluate the efficiency and outcomes of all consecutive emergent hemodialysis access procedures during a 3-month period at a single high volume VAC. Data collection for each procedure included anatomic outcome, clinical outcome, the amount of time from referral to procedure and to successful dialysis, 2-week-follow-up to screen for postprocedure complications and fluoroscopy time. A total of 157 emergent procedures were performed in 136 patients with the majority of interventions on nonfunctioning grafts and tunneled catheters. The overall clinical success (defined as successful postprocedure completion of at least one dialysis treatment at the prescribed blood flow) was achieved in 149 out of 157 (95%) cases. 90% of subjects completed their procedure within 24 hours of the initial referral to the VAC. The study also demonstrated a rapid turn around time, with successful dialysis being performed within 24 hours of referral in 61% and within 48 hours in 90% of referrals. This is the first study to demonstrate both the efficiency and successful outcomes of an outpatient vascular access center in treating emergent vascular access problems.
- 17 July 2007
- Published by Wiley in Seminars in Dialysis
- Vol. 20 (4) , 346-350
Efficiency and Outcomes of Emergent Vascular Access Procedures Performed at a Dedicated Outpatient Vascular Access Center
The outpatient vascular access center (VAC) may have an important impact in improving the outcomes of emergent procedures on nonfunctioning hemodialysis access. An emergent procedure is defined as the absence of a functioning access for hemodialysis, including thrombosed graft or fistula, nonfunctioning dialysis catheters, and the need for access to initiate emergent hemodialysis. The aim of this study was to prospectively evaluate the efficiency and outcomes of all consecutive emergent hemodialysis access procedures during a 3-month period at a single high volume VAC. Data collection for each procedure included anatomic outcome, clinical outcome, the amount of time from referral to procedure and to successful dialysis, 2-week-follow-up to screen for postprocedure complications and fluoroscopy time. A total of 157 emergent procedures were performed in 136 patients with the majority of interventions on nonfunctioning grafts and tunneled catheters. The overall clinical success (defined as successful postprocedure completion of at least one dialysis treatment at the prescribed blood flow) was achieved in 149 out of 157 (95%) cases. 90% of subjects completed their procedure within 24 hours of the initial referral to the VAC. The study also demonstrated a rapid turn around time, with successful dialysis being performed within 24 hours of referral in 61% and within 48 hours in 90% of referrals. This is the first study to demonstrate both the efficiency and successful outcomes of an outpatient vascular access center in treating emergent vascular access problems.
- 1 December 2006
- Published by Wiley in Seminars in Dialysis
- Vol. 19 (6) , 525-526
Coding Issues for the Interventionalist: A Consensus Statement by the ASDIN
The field of Interventional Nephrology has matured and expanded over the last decade. The American Society of Diagnostic and Interventional Nephrology (ASDIN) has recognized the need for standardization and uniformity in coding of interventional procedures on dialysis access. After extensive study, an ASDIN committee developed a coding manual in 2004 with revisions in 2005 and 2006, which is available to ASDIN members through the ASDIN web site. This article comprises a brief overview of appropriate coding for access related procedures and contrasts the ASDIN recommendations with a recent interventional radiology generated approach.
- 1 December 2006
- Published by Wiley in Seminars in Dialysis
- Vol. 19 (6) , 525-526
Coding Issues for the Interventionalist: A Consensus Statement by the ASDIN
The field of Interventional Nephrology has matured and expanded over the last decade. The American Society of Diagnostic and Interventional Nephrology (ASDIN) has recognized the need for standardization and uniformity in coding of interventional procedures on dialysis access. After extensive study, an ASDIN committee developed a coding manual in 2004 with revisions in 2005 and 2006, which is available to ASDIN members through the ASDIN web site. This article comprises a brief overview of appropriate coding for access related procedures and contrasts the ASDIN recommendations with a recent interventional radiology generated approach.
- 3 July 2003
- Published by Wiley in Seminars in Dialysis
- Vol. 16 (4) , 314-322
Interventional Nephrology and Dialysis: Managing the Complications of Long‐Term Tunneled Dialysis Catheters
The Kidney Disease Outcomes and Quality Initiative (K/DOQI) guidelines call for a significant increase in the use of natural vein fistulas. Long-term tunneled dialysis catheters (LTTDCs) will have an important role in facilitating the maturation of natural vein fistulas. LTTDCs also functions as the access of last resort in patients who refuse or have exhausted other forms of permanent vascular access. This article, which is based on the authors' experience as interventional nephrologists, discusses factors influencing catheter function. In addition, the article reviews common complications associated with dialysis catheter insertion, including immediate, short-term, and long-term complications. The topics reviewed include stenoses, thrombus formation, fibrin sheath formation, infections, and vascular ingrowth. Suggestions for management are also discussed.
- 3 July 2003
- Published by Wiley in Seminars in Dialysis
- Vol. 16 (4) , 314-322
Interventional Nephrology and Dialysis: Managing the Complications of Long‐Term Tunneled Dialysis Catheters
The Kidney Disease Outcomes and Quality Initiative (K/DOQI) guidelines call for a significant increase in the use of natural vein fistulas. Long-term tunneled dialysis catheters (LTTDCs) will have an important role in facilitating the maturation of natural vein fistulas. LTTDCs also functions as the access of last resort in patients who refuse or have exhausted other forms of permanent vascular access. This article, which is based on the authors' experience as interventional nephrologists, discusses factors influencing catheter function. In addition, the article reviews common complications associated with dialysis catheter insertion, including immediate, short-term, and long-term complications. The topics reviewed include stenoses, thrombus formation, fibrin sheath formation, infections, and vascular ingrowth. Suggestions for management are also discussed.
- 12 May 2003
- Published by Wiley in Seminars in Dialysis
- Vol. 16 (3) , 272-275
Pharmacomechanical Thrombolysis of Natural Vein Fistulas: Reduced Dose of TPA and Long‐Term Follow‐Up
Twenty‐five episodes of pharmacomechanical thrombolysis of 20 clotted arteriovenous fistulas (AVFs) are reported. The technique presented utilizes the local instillation of tissue plasminogen activator (TPA) in small doses together with manual maceration to dissolve clot and balloon angioplasty to correct the underlying stenoses. Since the minimum dose of TPA necessary to successfully perform thrombolysis of a natural vein fistula had never been determined, an attempt to use as minimal a dose of TPA as possible was made. Five procedures were performed in fistulas which had previously undergone a thrombolysis procedure with TPA. The procedures were successful in 92% of cases with an average dose of TPA required of 2.3 ± 0.32 mg/procedure. In addition to the 20 accesses in this article, we offer follow‐up life table data on 15 fistulas that were previously reported for a total of 35 accesses salvaged with pharmacomechanical thrombolysis. Primary patency was 11.2 months and secondary patency was 25 months. Fifty‐five percent of fistulas required repeat angioplasty procedures at an average of 3.6‐month intervals. In addition, more than half of the fistulas that presented with clotting required repeat interventions for continued patency. This report demonstrates the effectiveness of small doses of TPA in successful pharmacomechanical thrombolysis of clotted fistulas.
- 12 May 2003
- Published by Wiley in Seminars in Dialysis
- Vol. 16 (3) , 272-275
Pharmacomechanical Thrombolysis of Natural Vein Fistulas: Reduced Dose of TPA and Long‐Term Follow‐Up
Twenty‐five episodes of pharmacomechanical thrombolysis of 20 clotted arteriovenous fistulas (AVFs) are reported. The technique presented utilizes the local instillation of tissue plasminogen activator (TPA) in small doses together with manual maceration to dissolve clot and balloon angioplasty to correct the underlying stenoses. Since the minimum dose of TPA necessary to successfully perform thrombolysis of a natural vein fistula had never been determined, an attempt to use as minimal a dose of TPA as possible was made. Five procedures were performed in fistulas which had previously undergone a thrombolysis procedure with TPA. The procedures were successful in 92% of cases with an average dose of TPA required of 2.3 ± 0.32 mg/procedure. In addition to the 20 accesses in this article, we offer follow‐up life table data on 15 fistulas that were previously reported for a total of 35 accesses salvaged with pharmacomechanical thrombolysis. Primary patency was 11.2 months and secondary patency was 25 months. Fifty‐five percent of fistulas required repeat angioplasty procedures at an average of 3.6‐month intervals. In addition, more than half of the fistulas that presented with clotting required repeat interventions for continued patency. This report demonstrates the effectiveness of small doses of TPA in successful pharmacomechanical thrombolysis of clotted fistulas.